icon-folder.gif   Conference Reports for NATAP  
 
  16th International Workshop
on Clinical Pharmacology of HIV
and Hepatitis Therapy
May 26-28, 2015
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Rilpivirine population pharmacokinetic modeling in
antiretroviral-na´ve, HIV-1-infected adolescents in PAINT

 
 
  Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, Washington, WA, USA, May 26-28 2015
 
Anne Brochot, Annemie Hoogstoel, Simon Vanveggel, Marita Stevens, Herta M Crauwels
Janssen Infectious Diseases BVBA, Beerse, Belgium
 
CROI/2014: Rilpivirine pharmacokinetics in HIV-1-infected adolescents:
a substudy of PAINT (Phase II trial).......http://www.natap.org/2014/CROI/croi_174.htm

pharm1.gif

pharm2.gif

pharm3.gif

pharm4.gif

pharm5.gif

pharm6.gif

pharm7.gif